Marko S. Zatylny


  • JD, Harvard Law School, 2002
  • BS (Accounting), magna cum laude, Brigham Young University, 1998


  • Massachusetts, 2002

Marko S. Zatylny


Marko focuses his practice on advising public and private companies, investment banks and investment funds in mergers & acquisitions, capital markets transactions and corporate governance issues. He handles transactions for clients in a number of industries, including life sciences, financial services, energy/cleantech and retail and consumer. His clients include companies such as Becton Dickinson, Domino’s Pizza, Keurig Green Mountain, LPL Financial, Novavax and Wright Medical Technology. Marko is co-chair of the firm’s energy/cleantech practice. In April 2012, Marko was named “Deal Maker of the Week” by The American Lawyer.


  • Representing the lead underwriters in the initial public offering of Cerulean Pharma Inc.
  • Represented the lead underwriters in the follow-on offering of Insmed Incorporated
  • Represented Novavax in its cross-border tender offer for the outstanding shares of Isconova, a Sweden-based publicly traded vaccine adjuvant company.
  • Representing Wright Medical Technology in its sale of its OrthoRecon business to MicroPort Scientific Corporation.
  • Represented Becton Dickinson, a global medical technology company, in a number of divestitures and acquisitions, including in its recent sale of its Discovery Labware unit and acquisition of Safety Syringes, Inc. 
  • Represented Pfizer, the world's largest research-based pharmaceutical company, in its acquisition of Excaliard Pharmaceuticals, a biopharmaceutical company focused on the development of novel drugs for the treatment of skin scarring. 
  • Represented the lead underwriters in the initial public offering and subsequent follow-on offering of Bloomin’ Brands, Inc., one of the largest casual dining restaurant companies in the world. 
  • Represented LPL Financial Holdings, the holding company for one of the largest brokerage firms in the U.S., in its $522 million initial public offering and subsequent follow on offerings. 
  • Represented Keurig Green Mountain, a provider and marketer of coffee in the United States and internationally, in its recent $610 million follow on equity offering. 
  • Represented Covidien, a leading global provider of health care products, in several acquisitions, including in its acquisitions of ev3 and Aspect Medical Systems. 
  • Represented clients in acquisitions of energy/utility assets and the negotiation of various power and energy contracts, including in the renewable energy sector.


  • IFLR1000: The Guide to the World’s Leading Financial Law Firms, Rising Star (2014-2015)
  • Dealmaker of the WeekThe American Lawyer (2012)




  • Panelist, "From the Boardroom: Considerations in Option to Purchase Deals," Ropes & Gray Life Sciences Roundtable, San Francisco, January 12, 2014